Skip to main content
. Author manuscript; available in PMC: 2011 Dec 16.
Published in final edited form as: Vaccine. 2010 Nov 2;29(2):212–220. doi: 10.1016/j.vaccine.2010.10.053

TABLE 2. Design of Study of Henipavirus F.

Immunization of Mice with Wild-Type VRP Expressing HeVF or NiVF.

Replicon Transgene Dose (IU) a Group Designation
Wild Type HeVF 50 μl VRPs b V-HeVF
Wild Type NiVF 50 μl VRPs b V-NiVF
Wild type R2gp160 1 × 106 V-R2gp160
None N/A N/A Control
a

Infectious units.

b

VRP dose for each individual mouse per group was the same, ensured by using a fixed homogenous pool of VRP preparation for all immunizations; replicon particle titers could not be calculated due to lack of a suitable antibody for use in immunofluorescent assays.